News

Researchers have developed a brain-permeable compound (25-106) that targets a signaling regulator in brain neurons. The team notes that when the new compound was administered to mice, it could alter their neurobehavior and reduce anxiety-like behavior.

Investigators say that a standard test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, IgD multiple myeloma.

A natural disaster, a dented car, an injured person - memories of traumatic experiences can be controlled by deliberately suppressing the images that arise. Researchers have now shown that this process causes memories of the experiences to fade.

A new study by researchers from the University of Chicago, the University of Washington, and the University of Illinois Chicago (UIC) shows that the optic gland in maternal octopuses undergoes a massive shift in cholesterol metabolism, resulting in dramatic changes in the steroid hormones produced.

A team of researchers at the University of Copenhagen has discovered a new piece in the puzzle of the brain’s ‘feel good’ substance, dopamine.

Investigators at Brigham and Women’s Hospital and Harvard Medical School have devised a novel therapeutic method using stem cells taken from healthy donors to treat glioblastomas post-surgery by attacking glioblastoma-specific tumor cells.

A gene-targeting approach could help prevent or treat neonatal brain injuries associated with oxidative stress following preterm birth.

Trinity scientists, along with international colleagues, have explored the importance of sea travel in prehistory by examining the genomes of ancient Maltese humans and comparing these with the genomes of this period from across Europe.

In the first study of its kind, Penn researchers and an international team of collaborators found that genetics and environmental factors contribute to how socioeconomic status shapes the architecture of the brain.

A new study published in Clinical Cardiology found that colchicine, A common gout medication, significantly improves survival rates for patients hospitalized with worsening heart failure.